Last reviewed · How we verify

NCT03509597: CORTEX-SP

Brain Image Markers Associated With Cognitive Training and Aerobic Exercise in Schizophrenia

Status unknown NA Last updated 30 July 2019
What this trial tests

NA trial testing Aerobic Exercise in Schizophrenia in 150 participants. Status unknown.

Timeline
1 March 2017
Primary endpoint
31 December 2019
1 June 2020

Quick facts

Lead sponsorRed Salud Mental Araba
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment150
Start date1 March 2017
Primary completion31 December 2019
Estimated completion1 June 2020
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Red Salud Mental Araba

Who can join

Adults 18 to 65, any sex, with Schizophrenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the brain correlates of Cognitive Training and Aerobic Exercise in schizophrenia. A third of participants will receive Cognitive Training plus Standard Care for schizophrenia. Another third of participants will receive Aerobic Exercise Training plus Standard Care for schizophrenia. A control group will of participants will receive Standard Care plus Occupational Activities for the same duration and frequency as the experimental groups.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Cognitive, creative, functional, and clinical symptom improvements in schizophrenia after an integrative cognitive remediation program: a randomized controlled trial.
    Sampedro A, Peña J, Sánchez P, Ibarretxe-Bilbao N, et al · · 2021 · cited 12× · PMID 34711835 · DOI 10.1038/s41537-021-00181-0
  2. Mediating role of cognition and social cognition on creativity among patients with schizophrenia and healthy controls: Revisiting the Shared Vulnerability Model.
    Sampedro A, Peña J, Ibarretxe-Bilbao N, Sánchez P, et al · · 2020 · cited 9× · PMID 31707749 · DOI 10.1111/pcn.12954
  3. Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study: Characterization of adults with schizophrenia.
    Tous-Espelosin M, de Azua SR, Iriarte-Yoller N, MartínezAguirre-Betolaza A, et al · · 2021 · cited 6× · PMID 33246589 · DOI 10.1016/j.psychres.2020.113580
  4. Brain White Matter Correlates of Creativity in Schizophrenia: A Diffusion Tensor Imaging Study.
    Sampedro A, Peña J, Ibarretxe-Bilbao N, Cabrera-Zubizarreta A, et al · · 2020 · cited 3× · PMID 32655352 · DOI 10.3389/fnins.2020.00572
  5. The impact of creativity on functional outcome in schizophrenia: a mediational model.
    Sampedro A, Peña J, Sánchez P, Ibarretxe-Bilbao N, et al · · 2021 · cited 2× · PMID 33637749 · DOI 10.1038/s41537-021-00144-5
  6. Differential Responsiveness to Exercise and Cognitive Remediation in Physical Health in People With Schizophrenia: Results From the CORTEX-SP Study.
    Tous-Espelosin M, Iriarte-Yoller N, Sampedro A, Lasa-Sagaseta I, et al · · 2026 · PMID 42141376 · DOI 10.1002/ejsc.70182
  7. Theory-of-mind improvement in schizophrenia after integrative cognitive remediation: which patients benefit more?
    Sampedro A, Peña J, Sánchez P, Ibarretxe-Bilbao N, et al · · 2025 · PMID 40735250 · DOI 10.1016/j.scog.2025.100380
  8. As We Were and As We Should Be, Combined Exercise Training in Adults With Schizophrenia: CORTEX-SP Study Part II.
    Tous-Espelosin M, Pavon C, Elizagarate E, Sampedro A, et al · · 2024 · PMID 39054763 · DOI 10.1111/sms.14707

Verify or expand the search:

Other trials of Aerobic Exercise

Trials testing the same drug.

Other recruiting trials for Schizophrenia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03509597.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing